Viewing Compound With Targets


Compound Report Overview

Compound Name: ZONISAMIDE
Compound Identifier: 702781
Mol Structure 2D: 702781
Molecular Weight: 212
Formula: C8 H8 N2 O3 S
Development Status: US FDA Approved, April 2000
SMILES: NS(=O)(=O)Cc1noc2ccccc12
Compound Targets
Compound Gene Gene Type View
ZONISAMIDE 168887 amiloride-sensitive cation channel 5, intestinal View
ZONISAMIDE 135381 sodium channel, voltage-gated, type VII, alpha View
ZONISAMIDE 135191 sodium channel, voltage-gated, type I, beta View
ZONISAMIDE 137182 sodium channel, voltage-gated, type IV, alpha polypeptide View
ZONISAMIDE 132900 sodium channel, voltage-gated, type XI, alpha View
ZONISAMIDE 153849 sodium channel, nonvoltage-gated 1 alpha View
ZONISAMIDE 153848 sodium channel, nonvoltage-gated 1 beta View
ZONISAMIDE 165452 sodium channel, voltage-gated, type II, beta View
ZONISAMIDE 150734 sodium channel, voltage-gated, type V, alpha polypeptide View
ZONISAMIDE 165421 sodium channel, voltage-gated, type IX, alpha View
ZONISAMIDE 165479 sodium channel, voltage-gated, type 2, alpha 1 polypeptide View
ZONISAMIDE 165775 sodium channel, voltage-gated, type VIII, alpha polypeptide View
ZONISAMIDE 127667 sodium channel, voltage-gated, type 10, alpha polypeptide View
ZONISAMIDE 127751 sodium channel, nonvoltage-gated 1 gamma View
ZONISAMIDE 133117 sodium channel, voltage-gated, type I, alpha View